NEPENTHE
Inflammatory Response
Udayana UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Inflammatory Response cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VITAMIN D Meir Medical Center | Phase 4 | BB |
Tranexamic Acid Assiut University | Phase 3 | B |
APIGUARD Centro Universitario de Ciencias de la Salud, Mexico | Phase 2 | CCC |
Etoricoxib Udayana University | N/A | D |
L-AMINO ACIDS Supplement Formulators, Inc. | N/A | D |
View all 9 →
Same molecule, other indications
NEPENTHE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →